[RGLS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 5.80%
YoY- -11.74%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,795 -7,551 -7,258 -6,718 -7,133 -8,628 -6,033 8.22%
Tax 1 -12 83 1 214 1 1 0.00%
NP -6,796 -7,539 -7,341 -6,719 -7,133 -8,628 -6,034 8.22%
Tax Rate - - - - - - - -
Total Cost 6,796 7,539 7,341 6,719 7,133 8,628 6,034 8.22%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.40 -0.50 -0.50 -0.46 -0.67 -0.99 -0.78 -35.85%
EPS Diluted -0.40 -0.50 -0.50 -0.46 -0.67 -0.99 -0.78 -35.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.